A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms

A new method for the simultaneous determination of paracetamol (PR) and lornoxicam (LR) has been developed by reversed phase HPLC from the combination drug product. The separation achieved on C18 column using acetonitrile and 0.02 M potassium dihydrogen phosphate was in the ratio of 35:6...

Full description

Bibliographic Details
Main Authors: Karunakaran Kulandaivelu, Navaneethan Gurusamy, Pitchaimuthu Kuppanagounder Elango
Format: Article
Language:English
Published: Association of the Chemical Engineers of Serbia 2014-01-01
Series:Chemical Industry and Chemical Engineering Quarterly
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/1451-9372/2014/1451-93721200106K.pdf
_version_ 1819155823412117504
author Karunakaran Kulandaivelu
Navaneethan Gurusamy
Pitchaimuthu Kuppanagounder Elango
author_facet Karunakaran Kulandaivelu
Navaneethan Gurusamy
Pitchaimuthu Kuppanagounder Elango
author_sort Karunakaran Kulandaivelu
collection DOAJ
description A new method for the simultaneous determination of paracetamol (PR) and lornoxicam (LR) has been developed by reversed phase HPLC from the combination drug product. The separation achieved on C18 column using acetonitrile and 0.02 M potassium dihydrogen phosphate was in the ratio of 35:65 (v/v) as mobile phase at a flow rate of 1.0 mL/min. Both the components were monitored at a single wavelength at 260 nm and the column temperature was maintained at 30°C throughout the analysis. A linear response was found in the concentration range of 125-375 μg/mL for PR and 2-6 μg/mL for LR, with the correlation coefficient of more than 0.999. Although the tablet contained a high dose of PR (500 mg) and a low dose of LR (8 mg), the single HPLC method was developed and the intra as well as inter day precision was obtained at less than 2% of RSD. The accuracy results obtained were between 98% and 102%. The drug was intentionally degraded under acidic, basic, peroxide, thermal, and photolytic conditions. The major degradation observed for both PR and LR under peroxide condition indicated that the drug product is susceptible to oxidation. The degraded peaks were properly resolved from PR and LR. Hence, the method is stability indicating.
first_indexed 2024-12-22T15:43:06Z
format Article
id doaj.art-72f4f02f358849f4a9ed1765cc86b554
institution Directory Open Access Journal
issn 1451-9372
2217-7434
language English
last_indexed 2024-12-22T15:43:06Z
publishDate 2014-01-01
publisher Association of the Chemical Engineers of Serbia
record_format Article
series Chemical Industry and Chemical Engineering Quarterly
spelling doaj.art-72f4f02f358849f4a9ed1765cc86b5542022-12-21T18:21:05ZengAssociation of the Chemical Engineers of SerbiaChemical Industry and Chemical Engineering Quarterly1451-93722217-74342014-01-0120110911410.2298/CICEQ120502106K1451-93721200106KA validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage formsKarunakaran Kulandaivelu0Navaneethan Gurusamy1Pitchaimuthu Kuppanagounder Elango2Department of Chemistry, Sona College of Technology (Anna University), Salem, IndiaDepartment of Chemistry, Sona College of Technology (Anna University), Salem, IndiaDepartment of Chemistry, Gandhigram Rural Institute (Deemed University), Gandhigram, IndiaA new method for the simultaneous determination of paracetamol (PR) and lornoxicam (LR) has been developed by reversed phase HPLC from the combination drug product. The separation achieved on C18 column using acetonitrile and 0.02 M potassium dihydrogen phosphate was in the ratio of 35:65 (v/v) as mobile phase at a flow rate of 1.0 mL/min. Both the components were monitored at a single wavelength at 260 nm and the column temperature was maintained at 30°C throughout the analysis. A linear response was found in the concentration range of 125-375 μg/mL for PR and 2-6 μg/mL for LR, with the correlation coefficient of more than 0.999. Although the tablet contained a high dose of PR (500 mg) and a low dose of LR (8 mg), the single HPLC method was developed and the intra as well as inter day precision was obtained at less than 2% of RSD. The accuracy results obtained were between 98% and 102%. The drug was intentionally degraded under acidic, basic, peroxide, thermal, and photolytic conditions. The major degradation observed for both PR and LR under peroxide condition indicated that the drug product is susceptible to oxidation. The degraded peaks were properly resolved from PR and LR. Hence, the method is stability indicating.http://www.doiserbia.nb.rs/img/doi/1451-9372/2014/1451-93721200106K.pdfRP-HPLCparacetamollornoxicamstability indicatingforced degradationvalidation
spellingShingle Karunakaran Kulandaivelu
Navaneethan Gurusamy
Pitchaimuthu Kuppanagounder Elango
A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
Chemical Industry and Chemical Engineering Quarterly
RP-HPLC
paracetamol
lornoxicam
stability indicating
forced degradation
validation
title A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
title_full A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
title_fullStr A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
title_full_unstemmed A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
title_short A validated stability-indicating RP-HPLC method for paracetamol and lornoxicam: Application to pharmaceutical dosage forms
title_sort validated stability indicating rp hplc method for paracetamol and lornoxicam application to pharmaceutical dosage forms
topic RP-HPLC
paracetamol
lornoxicam
stability indicating
forced degradation
validation
url http://www.doiserbia.nb.rs/img/doi/1451-9372/2014/1451-93721200106K.pdf
work_keys_str_mv AT karunakarankulandaivelu avalidatedstabilityindicatingrphplcmethodforparacetamolandlornoxicamapplicationtopharmaceuticaldosageforms
AT navaneethangurusamy avalidatedstabilityindicatingrphplcmethodforparacetamolandlornoxicamapplicationtopharmaceuticaldosageforms
AT pitchaimuthukuppanagounderelango avalidatedstabilityindicatingrphplcmethodforparacetamolandlornoxicamapplicationtopharmaceuticaldosageforms
AT karunakarankulandaivelu validatedstabilityindicatingrphplcmethodforparacetamolandlornoxicamapplicationtopharmaceuticaldosageforms
AT navaneethangurusamy validatedstabilityindicatingrphplcmethodforparacetamolandlornoxicamapplicationtopharmaceuticaldosageforms
AT pitchaimuthukuppanagounderelango validatedstabilityindicatingrphplcmethodforparacetamolandlornoxicamapplicationtopharmaceuticaldosageforms